What is ankylosing spondylitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ankylosing Spondylitis: Definition and Clinical Features

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by sacroiliitis, enthesitis, and a marked propensity for sacroiliac joint and spinal fusion, with universal involvement of sacroiliac joint inflammation or fusion and more prevalent spinal ankylosis. 1

Key Characteristics

  • Classification: AS is a form of axial spondyloarthritis (SpA), belonging to the spondyloarthritis family of diseases that share clinical, genetic, and immunologic features 1
  • Prevalence: Affects 0.1-0.5% of the population 1
  • Genetic Association: High prevalence of HLA-B27 (positive in 74-89% of patients) 2
  • Primary Sites of Inflammation:
    • Sacroiliac joints (universal involvement)
    • Spine (vertebral column)
    • Entheses (sites where tendons or ligaments attach to bone)

Clinical Manifestations

Cardinal Symptoms

  • Inflammatory Back Pain (70-80% of patients) characterized by:
    • Insidious onset before age 45
    • Symptoms lasting >3 months
    • Morning stiffness >30 minutes
    • Pain at night/early morning
    • Improvement with exercise but not with rest
    • Alternating buttock pain 2

Disease Progression

  • Early Disease: Inflammation of sacroiliac joints and spine
  • Advanced Disease: Progressive spinal stiffness, fusion, and deformity 3
  • End-Stage: Can lead to severe kyphosis, resulting in debilitating functional impairment 3

Extra-articular Manifestations

  • Uveitis (eye inflammation)
  • Psoriasis
  • Inflammatory bowel disease 2

Diagnostic Features

Radiographic Findings

  • Sacroiliitis: Erosions, sclerosis, joint space narrowing, and ankylosis 2
  • Spinal Changes: Syndesmophytes (bony growths), vertebral fusion, "bamboo spine" appearance

Laboratory Findings

  • HLA-B27: Positive in 74-89% of AS patients 2
  • Inflammatory Markers: Elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in active disease

Imaging

  • Radiography: First-line imaging for sacroiliac joints 2
  • MRI: Can detect early inflammatory changes before radiographic damage
    • Bone marrow edema is the hallmark of active sacroiliitis 2

Disease Classification

  • Radiographic axial SpA (AS): Meets modified New York criteria with definite radiographic sacroiliitis
  • Non-radiographic axial SpA: Chronic back pain and features suggestive of SpA but without radiographic sacroiliitis 1

Complications

  • Structural Damage: Spinal fusion and ankylosis
  • Fractures: Increased susceptibility to vertebral column fractures due to weakened spine 4
  • Spinal Cord Injury: Higher risk due to unstable nature of fractures in the ankylosed spine 4
  • Functional Limitations: Reduced mobility, difficulty with daily activities, and decreased quality of life 3

Disease Burden

  • Diagnostic Delay: Average 7-10 years from symptom onset to diagnosis 2
  • Work Impact: Can interfere with work and schooling 1
  • Quality of Life: Significant reduction in quality of life, especially in advanced cases 3

Understanding the defining features of AS is crucial for early diagnosis and appropriate management to prevent disease progression and maintain quality of life for affected individuals.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Spondyloarthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.